MicroRNA as a New Blood-Borne Novel Biomarker for the Earlier Diagnosis of Lung Cancer: OAJBS Publishers

 

MicroRNA as a New Blood-Borne Novel Biomarker for the Earlier Diagnosis of Lung Cancer by Muhammad Siraj* in Open Access Journal of Biomedical Science (OAJBS)

Throughout the world, lung cancer is the first leading cause of cancer-related death, estimating roundabout 1.6 million cancer deaths occur annually. Lung cancer with its highest incident and deaths/mortality all over the world due to its limited diagnosis and treatment strategies. The earlier diagnosis of lung cancer plays an important in its treatment. There are different techniques used for the diagnosis of lung cancer including sputum cytology, different nanoparticles, and biomarkers such as CYFRA 21-1, NSE, SCC, CEA, ProGRP, Tumor M2-PK, miRNA. The main objective of this study is the role of miRNA as a novel biomarker for the earlier diagnosis of lung cancer. MicroRNAs are a very effective diagnosis marker for the earlier detection of lung cancer with high specificity and sensitivity about 96.6% and 86.2% respectively.
https://biomedscis.com/fulltext/microrna-as-a-new-blood-borne-novel-biomarker-for-the-earlier-diagnosis-of-lung-cancer.ID.000256.php

To Know More About Open Access Journal of Biomedical Science Please Visit: Biomedscis

Are Click on:  https://Biomedscis.Com/

Comments

Popular posts from this blog

Review on Analysis of Breast Tumor with Methods of Treatment: OAJBS Publishers

Facile Synthesis of Chitosan Nanoparticle with Different Features and Histopathological Ultrastructural Study on The Effect of Its Bio-complex with Bovine Serum Albumin: OAJBS Publishers

Assessment of Medication Errors in Emergency Ward at Nekemte Referral Hospital, West Ethiopia: OAJBS Publishers